Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...

Anthropic says it would be “legally unsound” for the Pentagon to blacklist its technology after talks over military use of its artificial intelligence models broke down. “Effective immediately, no ...

WASHINGTON, Feb 27 (Reuters) - U.S. President Donald Trump said on Friday he is directing the government to stop work with Anthropic, and the Pentagon said it would declare the startup a supply-chain ...

A dispute stemming from questions about the use of AI firm's Anthropic’s model during the U.S. operation targeting Venezuelan leader Nicolás Maduro has triggered a Pentagon review of the company’s ...

Microwaves are a convenient appliance in your own kitchen. But when you’re spending money at a restaurant, even a fast-food chain, it’s nice to know that your food is freshly cooked and not heated in ...

NORTH BETHESDA, Md., Feb. 03, 2026 (GLOBE NEWSWIRE) -- As aerospace and defense (A&D) programs accelerate and production demands increase, organizations across the defense industrial base are ...

MIT researchers have designed silicon structures that can perform calculations in an electronic device using excess heat instead of electricity. These tiny structures could someday enable more ...

Fast food is often viewed as one of the cheapest ways to grab a meal, but some deals that look like bargains may be doing more to boost restaurant profits than protect consumers’ wallets. At the ...

On Jan. 21, Avalanche announced the launch of the C-Chain round of Retro9000, the retroactive grant program that rewards up to $40 million to developers strengthening the Avalanche ecosystem. One of ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...